KLA318-2 Nanocrystal Injection

KLA318-2 · Hunan Kelun Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KLA318-2 Nanocrystal Injection, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of KLA318-2 Nanocrystal Injection [Phase 1]